$BELFA (Bel Fuse Inc)

$BELFA {{ '2016-05-11T13:43:42+0000' | timeago}} • Announcement

$BELFA $BELFB said its BoD declared regular quarterly cash dividends of $0.06 per share on the company's Class A common shares and $0.07 per share on the company's Class B common shares.

$BA {{ '2017-07-26T18:19:22+0000' | timeago}} • Announcement

Dreamliner maker Boeing raised its earnings outlook for 2017. $BA now expects non-GAAP EPS of $9.80-10.00 vs. previous guidance for $9.20-9.40 and raised its GAAP EPS by $0.75 to between $11.10-11.30, its second upward revision in 2017. Revenue is still expected between $90.5-92.5Bil, including between 760 to 765 commercial deliveries.

$BA {{ '2017-07-26T17:55:57+0000' | timeago}} • Announcement

$BA said it expects to cut its 2017 capex by $300MM, which is not surprising as its biggest investments for 2017 are already out of the way. The company also said it would contribute $3.5Bil of common stock to its pension plan during 3Q, which is expected to provide $700MM in cash tax savings.

$BA {{ '2017-07-26T17:38:10+0000' | timeago}} • Announcement

$BA derives a significant portion of revenues from a handful of commercial airlines. For 2Q, commercial aircraft deliveries fell to 183 vs. 199 a year ago. Boeing still expects to deliver 760-765 jetliners in 2017. Defense segment sales fell 4% to $6.8Bil, but profit climbed 50% and operating margin improved 4% due to cost cutting efforts.

$BA {{ '2017-07-26T16:03:38+0000' | timeago}} • Announcement

Boeing, world's biggest plane maker, reported that its revenues fell 8% to $22.74Bil. However, the company swung to a profit of $1.76Bil vs. $234MM loss in 2Q16 due to the charges (> $2Bil) related to the 787, 747 and KC-46 tanker aircraft programs. $BA reported strong operating cash flow of $5Bil, of which 787 Dreamliner contributed about $530MM.

$APH {{ '2017-07-26T14:20:40+0000' | timeago}} • Announcement

$APH has inducted John Craig, former Chairman and CEO of $ENS, to the company’s BoD. Craig was instrumental in creating $ENS in 2000 and subsequently built the company into a global leader in stored energy solutions for industrial applications.

$TMO {{ '2017-07-26T14:06:23+0000' | timeago}} • Webcast

$TMO said the upward revision of 2017 financial outlook mainly reflected the less adverse foreign exchange environment. The company continues to expect 4% organic revenue growth for the year. Excluding the effect of foreign exchange headwinds, adjusted EPS is seen growing 12-14%. Adjusted operating margin is forecast to grow 50-60 basis points YoY.

$TMO {{ '2017-07-26T13:46:17+0000' | timeago}} • Webcast

Scientific equipment maker $TMO said pharma and biotec continued to be its strongest end markets in 2Q17, with mid-single digits growth. The company's growth strategy remains centered on launching innovative products and leveraging the scale in Asia Pacific and emerging markets. In 2Q17, Thermo Fisher completed $250MM of share buybacks.

$BA {{ '2017-07-26T13:21:53+0000' | timeago}} • Infographic

$BA Boeing Company Earnings AlphaGraphic: Q2 2017 Highlights

$TMO {{ '2017-07-26T12:48:19+0000' | timeago}} • Infographic

$TMO Thermo Fisher Scientific, Inc. Earnings AlphaGraphic: Q2 2017 highlights

$TMO {{ '2017-07-26T10:56:26+0000' | timeago}} • Announcement

Among $TMO’s business segments, Life Sciences Solutions posted a 3% YoY growth in 2Q17 revenues. Analytical Instruments segment revenues surged 47%, reflecting the acquisition of FEI Company last year. Revenues of the Specialty Diagnostics segment and Laboratory Products & Services segment advanced 1% and 4%, respectively, compared to 2Q16.

$TMO {{ '2017-07-26T10:42:34+0000' | timeago}} • Announcement

$TMO revised up its fiscal 2017 revenue guidance to the range of $19.71-$19.89Bil from the previous outlook of $19.51-$19.71Bil, indicating an 8-9% annual growth. The guidance of adjusted EPS has been raised to $9.15-$9.28 per share from the earlier forecast of $9.12-$9.28 per share, which will result in an 11-12% YoY increase.

$TMO {{ '2017-07-26T10:33:50+0000' | timeago}} • Announcement

Medical instruments maker $TMO reported strong results for 2Q17, continuing the recent trend. Earnings of the company, which is currently on an acquisition spree, jumped 20% YoY to $1.56 per share. Adjusted earnings, excluding special items, grew 13% to $2.3 per share. The bottom line growth was driven by a 10% increase in revenues to $4.99Bil.

$TGI {{ '2017-07-25T17:09:42+0000' | timeago}} • Announcement

$TGI signed agreement with $BA to provide various hydraulic and mechanical actuation assemblies for legacy $BA programs, including the Next-Generation 737, 737 MAX, 747-8, 767, 767-2C and 777, and for the 777X, $BA's newest family of twin-aisle airplanes.

$CR {{ '2017-07-25T13:21:51+0000' | timeago}} • Announcement

$CR's BoD declared regular 3Q17 dividend of $0.33 per share. The dividend is payable on Sept. 8, 2017 to shareholders of record as of the close of business on Aug. 31, 2017.

$BA {{ '2017-07-24T17:41:39+0000' | timeago}} • Announcement

$BA today unveiled its 2017 Pilot and Technician Outlook at EAA AirVenture Oshkosh, an annual gathering of aviation professionals. Boeing forecasts a demand for more than 1.2MM pilots and technicians over the next 20 years.

$DHR {{ '2017-07-20T15:06:40+0000' | timeago}} • Webcast

With nearly $900MM of free cash flow and strong conversion in 2Q17, $DHR is optimistic on further acqusitions. Adding to its strong cash flow, $DHR has $500MM to $1Bil worth of opportunities slated for 2H17. Notably, the company's two most recent large acquisitions, Pall and Cepheid, continues to perform well and became part of the core revenue.

$DHR {{ '2017-07-20T13:00:10+0000' | timeago}} • Announcement

For 3Q17, $DHR sees its GAAP EPS to range from $0.74 to $0.78 and non-GAAP EPS to range from $0.92 to $0.96. For FY17, GAAP EPS to range from $3.16 to $3.23 and non-GAAP EPS to range from $3.90 to $3.97.

$DHR {{ '2017-07-20T12:56:52+0000' | timeago}} • Announcement

$DHR, a science and technology company, reported a 15% YoY drop in net earnings for 2Q17 to $557.3MM, or $0.79 per share. Earnings, adjusted for one-time gains and costs, grew 10% to $0.99 per share. Sales rose 6% to $4.5Bil.

$DHR {{ '2017-07-20T12:12:31+0000' | timeago}} • Infographic

$DHR Danaher Corp. Earnings AlphaGraphic: Q2 2017 Highlights

$TMO {{ '2017-07-19T12:44:47+0000' | timeago}} • Announcement

$TMO priced an offering of EUR2.6Bil of senior notes. The issuance of the notes is expected to close on or about July 24, 2017. $TMO plans to use all of net proceeds to fund a portion of consideration payable for its acquisition of Patheon, including the repayment of debt of Patheon to be assumed by $TMO, which is estimated to be about $7.2Bil.

Recent Transcripts

TMO (Thermo Fisher Scientific, Inc.)
Wednesday, July 26 2017 - 12:30pm
DXPE (DXP Enterprises, Inc.)
Tuesday, July 25 2017 - 9:00pm
WAB (Westinghouse Air Brake Technologies Corporation)
Tuesday, July 25 2017 - 2:00pm
CR (Crane Co.)
Tuesday, July 25 2017 - 2:00pm
ASTE (Astec Industries Inc)
Tuesday, July 25 2017 - 2:00pm
MDR (McDermott International Inc.)
Tuesday, July 25 2017 - 12:30pm
SNA (Snap-on Incorporated)
Thursday, July 20 2017 - 2:00pm
DHR (Danaher Corp.)
Thursday, July 20 2017 - 12:00pm
BHE (Benchmark Electronics Inc.)
Wednesday, July 19 2017 - 9:00pm
MEI (Methode Electronics, Inc.)
Thursday, June 22 2017 - 3:00pm
A (Agilent Technologies Inc.)
Monday, May 22 2017 - 8:30pm
DXPE (DXP Enterprises, Inc.)
Monday, May 15 2017 - 9:00pm
SPA (Sparton Corp.)
Wednesday, May 10 2017 - 3:00pm
INTT (inTEST Corp.)
Thursday, May 4 2017 - 9:00pm
OLED (Universal Display Corp.)
Thursday, May 4 2017 - 9:00pm
AVX (AVX Corp.)
Friday, April 28 2017 - 2:00pm
APH (Amphenol Corporation)
Wednesday, April 26 2017 - 5:00pm
BA (The Boeing Company)
Wednesday, April 26 2017 - 2:30pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, April 26 2017 - 12:30pm
CR (Crane Co.)
Tuesday, April 25 2017 - 2:00pm

AlphaGraphics you may like